Brief: GC Biopharma Says Signs Agreement With Catalyst Biosciences For The Acquisition Of Rare Disease Pipeline In Hematology

Gyre Therapeutics

28/02/2023 03:12

Feb 27 (Reuters) - GC Biopharma:
    * GC BIOPHARMA SIGNS AGREEMENT WITH CATALYST BIOSCIENCES FOR
THE
ACQUISITION OF RARE DISEASE PIPELINE IN HEMATOLOGY
    * GC BIOPHARMA-SIGNED AN ASSET PURCHASE AGREEMENT WITH
CATALYST
BIOSCIENCES TO ACQUIRE 3 PROGRAMS RELATED TO ORPHAN HEMATOLOGY
DISORDERS

Source text for Eikon:  ID:nPn939TGva 
Further company coverage:  006280.KS 

 ((Reuters.Briefs@thomsonreuters.com;))